Date

Monday, July 26, 2021

Venue

Time

14:00 (GMT+7)

Agenda

AGMS:

1. Approval of the company's Annual Financial Statements including the ratification of the Financial Statements and the Board of Commissioners Oversight Report of the financial year 2020.
2. Approval on the use of the company net profit of the financial year 2020.
3. Approval of Election of a Public Accountant Firm in the financial year 2021.
4. Delegation of authority to Board of Commissioners to act on behalf of the General Meeting of Shareholders in terms of determining the duty divisions and authorities of Board of Directors and determining remuneration for Board of Directors and Board of Commissioners.
5. Proceeds usage report from the Initial Public Offering (IPO) and the Series I Warrant Conversion.

EGMS

1. Approval to increase the issued and paid-up capital of the company with the new shares issuance through the capital increase with Pre-emptive Rights (PMHMETD) with a maximum amount of 3,570,000,000 (three billion five hundred seventy million) new shares accompanied by the issuance of Series II Warrants of as many as 3,570,000,000 (three billion five hundred seventy million) -a maximum of 280,000,000 (two hundred and eighty million) as referred in the Regulation of the Financial Services Authority (POJK) Number 32/POJK.04/2015 regarding the capital increase of a Public Company with Pre-emptive Rights in conjunction with the Regulation of the Financial Services Authority no. 14/POJK.04/2019 regarding the amendments to Financial Services Authority Regulation Number 32/POJK.04/2015 regarding the capital increase of a Public Company with Pre-emptive Rights.
2. Approval for the delegation of authority to Board of Directors
3. Approval for the purchase of the company's production machinery, which is a material transaction of the company.